dabrafenib and its Impurities

Dabrafenib is a reversible ATP-competitive kinase inhibitor and targets the MAPK pathway. It is used alone or in combination with another medication to treat a type of skin cancer.. Reference standards of Dabrafenib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 45 results for dabrafenib Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 31 06000

Dabrafenib

Dabrafenib

  • Catalogue No.:PA 31 06000

  • CAS :

    1195765-45-7

  • Molecular Formula : C23H20F3N5O2S2

  • Molecular Weight : 519.56

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 06510

3-Bromo-2-fluorobenzoic Acid

3-Bromo-2-fluorobenzoic Acid

  • Catalogue No.:PA 31 06510

  • CAS :

    161957-56-8

  • Molecular Formula : C7H4BrFO2

  • Molecular Weight : 219.01

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 06520

Dabrafenib Mesylate

Dabrafenib Mesylate

  • Catalogue No.:PA 31 06520

  • CAS :

    1195768-06-9

  • Molecular Formula : C24H24F3N5O5S3

  • Molecular Weight : 615.67

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 06530

2,6-Difluorobenzenesulfonyl Chloride

2,6-Difluorobenzenesulfonyl Chloride

  • Catalogue No.:PA 31 06530

  • CAS :

    60230-36-6

  • Molecular Formula : C6H3ClF2O2S

  • Molecular Weight : 212.6

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 06540

2,2-Dimethylthiopropionamide

2,2-Dimethylthiopropionamide

  • Catalogue No.:PA 31 06540

  • CAS :

    630-22-8

  • Molecular Formula : C5H11NS

  • Molecular Weight : 117.21

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061000

2-Amino-N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-6-fluorobenzenesulfonamide

2-Amino-N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-6-fluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061000

  • CAS :

    2017554-98-0

  • Molecular Formula : C23H22F2N6O2S2

  • Molecular Weight : 516.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061001

Carboxy Dabrafenib

Carboxy Dabrafenib

  • Catalogue No.:PA 31 0061001

  • CAS :

    1195873-54-1

  • Molecular Formula : C23H18F3N5O4S2

  • Molecular Weight : 549.54

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061002

Hydroxy Dabrafenib

Hydroxy Dabrafenib

  • Catalogue No.:PA 31 0061002

  • CAS :

    1195767-77-1

  • Molecular Formula : C23H20F3N5O3S2

  • Molecular Weight : 535.56

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061003

Desmethyl Dabrafenib

Desmethyl Dabrafenib

  • Catalogue No.:PA 31 0061003

  • CAS :

    1195765-47-9

  • Molecular Formula : C22H18F3N5O2S2

  • Molecular Weight : 505.53

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 089392

Dabrafenib-d9

Dabrafenib-d9

  • Catalogue No.:PA STI 089392

  • CAS :

    1423119-98-5

  • Molecular Formula : C23H11D9F3N5O2S2

  • Molecular Weight : 528.62

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061004

2,4-Difluorobenzenesulfonyl Chloride

2,4-Difluorobenzenesulfonyl Chloride

  • Catalogue No.:PA 31 0061004

  • CAS :

    13918-92-8

  • Molecular Formula : C6H3ClF2O2S

  • Molecular Weight : 212.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061005

4-Bromo-2-fluorobenzenesulfonyl Chloride

4-Bromo-2-fluorobenzenesulfonyl Chloride

  • Catalogue No.:PA 31 0061005

  • CAS :

    216159-03-4

  • Molecular Formula : C6H3BrClFO2S

  • Molecular Weight : 273.5

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061006

2,4,6-Trifluorobenzene-1-sulfonyl Chloride

2,4,6-Trifluorobenzene-1-sulfonyl Chloride

  • Catalogue No.:PA 31 0061006

  • CAS :

    220239-64-5

  • Molecular Formula : C6H2ClF3O2S

  • Molecular Weight : 230.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061007

2-Fluoro-6-methoxybenzenesulphonyl Chloride

2-Fluoro-6-methoxybenzenesulphonyl Chloride

  • Catalogue No.:PA 31 0061007

  • CAS :

    1176126-31-0

  • Molecular Formula : C7H6ClFO3S

  • Molecular Weight : 224.63

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061008

Methyl 3-amino-4-fluorobenzoate

Methyl 3-amino-4-fluorobenzoate

  • Catalogue No.:PA 31 0061008

  • CAS :

    369-26-6

  • Molecular Formula : C8H8FNO2

  • Molecular Weight : 169.16

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061009

Methyl 3-amino-5-fluorobenzoate

Methyl 3-amino-5-fluorobenzoate

  • Catalogue No.:PA 31 0061009

  • CAS :

    884497-46-5

  • Molecular Formula : C8H8FNO2

  • Molecular Weight : 169.16

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061010

Methyl 5-amino-2-fluorobenzoate

Methyl 5-amino-2-fluorobenzoate

  • Catalogue No.:PA 31 0061010

  • CAS :

    56741-34-5

  • Molecular Formula : C8H8FNO2

  • Molecular Weight : 169.16

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061011

3-Amino-2-fluorobenzoic Acid

3-Amino-2-fluorobenzoic Acid

  • Catalogue No.:PA 31 0061011

  • CAS :

    914223-43-1

  • Molecular Formula : C7H6FNO2

  • Molecular Weight : 155.13

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061012

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2-fluoro-6-methoxybenzenesulfonamide

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2-fluoro-6-methoxybenzenesulfonamide

  • Catalogue No.:PA 31 0061012

  • CAS :

    NA

  • Molecular Formula : C24H23F2N5O3S2

  • Molecular Weight : 531.6

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061013

2-Fluoro-6-nitrobenzenesulfonyl Chloride

2-Fluoro-6-nitrobenzenesulfonyl Chloride

  • Catalogue No.:PA 31 0061013

  • CAS :

    887266-98-0

  • Molecular Formula : C6H3ClFNO4S

  • Molecular Weight : 239.6

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061014

Methyl 3-amino-2-methoxybenzoate

Methyl 3-amino-2-methoxybenzoate

  • Catalogue No.:PA 31 0061014

  • CAS :

    5129-25-9

  • Molecular Formula : C9H11NO3

  • Molecular Weight : 181.19

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061015

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)phenyl)-2,6-difluorobenzenesulfonamide

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)phenyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061015

  • CAS :

    NA

  • Molecular Formula : C23H21F2N5O2S2

  • Molecular Weight : 501.57

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061016

N-(3-(2-(Tert-butyl)-5-(2-(dimethylamino)pyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

N-(3-(2-(Tert-butyl)-5-(2-(dimethylamino)pyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061016

  • CAS :

    NA

  • Molecular Formula : C25H24F3N5O2S2

  • Molecular Weight : 547.62

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061017

M30-Dabrafenib

M30-Dabrafenib

  • Catalogue No.:PA 31 0061017

  • CAS :

    1613724-38-1

  • Molecular Formula : C22H16F3N5O5S2

  • Molecular Weight : 551.52

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061018

M31-Dabrafenib

M31-Dabrafenib

  • Catalogue No.:PA 31 0061018

  • CAS :

    1613724-51-8

  • Molecular Formula : C22H16F3N5O2S2

  • Molecular Weight : 503.52

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061019

Dabrafenib Glucuronide

Dabrafenib Glucuronide

  • Catalogue No.:PA 31 0061019

  • CAS :

    2147682-66-2

  • Molecular Formula : C28H24F3N5O9S2

  • Molecular Weight : 695.64

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061020

1-(2-chloropyrimidin-4-yl)-2-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)-2-oxoethyl 2,2-dimethylpropanimidothioate

1-(2-chloropyrimidin-4-yl)-2-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)-2-oxoethyl 2,2-dimethylpropanimidothioate

  • Catalogue No.:PA 31 0061020

  • CAS :

    NA

  • Molecular Formula : C23H20ClF3N4O3S2

  • Molecular Weight : 557

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061021

Methyl 3-((2,6-difluorophenyl)sulfonamido)-2-fluorobenzoate

Methyl 3-((2,6-difluorophenyl)sulfonamido)-2-fluorobenzoate

  • Catalogue No.:PA 31 0061021

  • CAS :

    1195768-19-4

  • Molecular Formula : C14H10F3NO4S

  • Molecular Weight : 345.29

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061022

N-(3-(2-(tert-Butyl)-5-(2-hydroxypyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

N-(3-(2-(tert-Butyl)-5-(2-hydroxypyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061022

  • CAS :

    NA

  • Molecular Formula : C23H19F3N4O3S2

  • Molecular Weight : 520.55

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061023

2,6-Difluoro-N-(2-fluoro-3-(2-(2-hydroxypyrimidin-4-yl)acetyl)phenyl)benzenesulfonamide

2,6-Difluoro-N-(2-fluoro-3-(2-(2-hydroxypyrimidin-4-yl)acetyl)phenyl)benzenesulfonamide

  • Catalogue No.:PA 31 0061023

  • CAS :

    NA

  • Molecular Formula : C18H12F3N3O4S

  • Molecular Weight : 423.37

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061024

2,6-Difluorobenzenesulfonyl Fluoride

2,6-Difluorobenzenesulfonyl Fluoride

  • Catalogue No.:PA 31 0061024

  • CAS :

    447460-43-7

  • Molecular Formula : C6H3F3O2S

  • Molecular Weight : 196.14

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061025

N-(3-(2-(tert-Butyl)-4-hydroxy-5-(2-hydroxypyrimidin-4-yl)-4,5-dihydrothiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

N-(3-(2-(tert-Butyl)-4-hydroxy-5-(2-hydroxypyrimidin-4-yl)-4,5-dihydrothiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061025

  • CAS :

    NA

  • Molecular Formula : C23H21F3N4O4S2

  • Molecular Weight : 538.56

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061026

N-(3-(2-(Tert-butyl)-5-(2-chloropyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

N-(3-(2-(Tert-butyl)-5-(2-chloropyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061026

  • CAS :

    1195768-23-0

  • Molecular Formula : C23H18ClF3N4O2S2

  • Molecular Weight : 538.99

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061027

Methyl 2-fluoro-3-((2-fluoro-6-hydroxyphenyl)sulfonamido)benzoate

Methyl 2-fluoro-3-((2-fluoro-6-hydroxyphenyl)sulfonamido)benzoate

  • Catalogue No.:PA 31 0061027

  • CAS :

    NA

  • Molecular Formula : C14H11F2NO5S

  • Molecular Weight : 343.3

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061028

Dabrafenib Amine Impurity

Dabrafenib Amine Impurity

  • Catalogue No.:PA 31 0061028

  • CAS :

    1195769-01-7

  • Molecular Formula : C17H18FN5S

  • Molecular Weight : 343.42

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061029

N-(3-(2-(2-Aminopyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

N-(3-(2-(2-Aminopyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061029

  • CAS :

    NA

  • Molecular Formula : C18H13F3N4O3S

  • Molecular Weight : 422.38

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061030

Dabrafenib Diamine Sulfonamide Impurity

Dabrafenib Diamine Sulfonamide Impurity

  • Catalogue No.:PA 31 0061030

  • CAS :

    NA

  • Molecular Formula : C23H22F2N6O2S2

  • Molecular Weight : 516.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061031

5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)-4-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)thiazole 3-oxide

5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)-4-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)thiazole 3-oxide

  • Catalogue No.:PA 31 0061031

  • CAS :

    NA

  • Molecular Formula : C23H20F3N5O3S2

  • Molecular Weight : 535.56

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061032

2-Amino-4-(2-(tert-butyl)-4-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)thiazol-5-yl)pyrimidine 1-oxide

2-Amino-4-(2-(tert-butyl)-4-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)thiazol-5-yl)pyrimidine 1-oxide

  • Catalogue No.:PA 31 0061032

  • CAS :

    NA

  • Molecular Formula : C23H20F3N5O3S2

  • Molecular Weight : 535.56

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061033

Dabrafenib Methoxy Impurity

Dabrafenib Methoxy Impurity

  • Catalogue No.:PA 31 0061033

  • CAS :

    1907654-22-1

  • Molecular Formula : C24H21F3N4O3S2

  • Molecular Weight : 534.57

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061034

Dabrafenib des-(tert-butyl)thiazol chloro impurity

Dabrafenib des-(tert-butyl)thiazol chloro impurity

  • Catalogue No.:PA 31 0061034

  • CAS :

    1195768-20-7

  • Molecular Formula : C18H11ClF3N3O3S

  • Molecular Weight : 441.81

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061035

1-(3-Amino-2-fluorophenyl)-2-(2-chloropyrimidin-4-yl)ethan-1-one

1-(3-Amino-2-fluorophenyl)-2-(2-chloropyrimidin-4-yl)ethan-1-one

  • Catalogue No.:PA 31 0061035

  • CAS :

    NA

  • Molecular Formula : C12H9ClFN3O

  • Molecular Weight : 265.67

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061036

N-(3-(2-(2-Chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-N-((2,6-difluorophenyl)sulfonyl)-2,6-difluorobenzenesulfonamide

N-(3-(2-(2-Chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-N-((2,6-difluorophenyl)sulfonyl)-2,6-difluorobenzenesulfonamide

  • Catalogue No.:PA 31 0061036

  • CAS :

    NA

  • Molecular Formula : C24H13ClF5N3O5S2

  • Molecular Weight : 617.95

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061037

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2-fluoro-6-hydroxybenzenesulfonamide

N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2-fluoro-6-hydroxybenzenesulfonamide

  • Catalogue No.:PA 31 0061037

  • CAS :

    NA

  • Molecular Formula : C23H21F2N5O3S2

  • Molecular Weight : 517.57

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 31 0061038

(E)-N-(3-(1-Aminoprop-1-en-1-yl)-2-fluorophenyl)benzenesulfonamide

(E)-N-(3-(1-Aminoprop-1-en-1-yl)-2-fluorophenyl)benzenesulfonamide

  • Catalogue No.:PA 31 0061038

  • CAS :

    NA

  • Molecular Formula : C15H15FN2O2S

  • Molecular Weight : 306.36

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates